JPS57500768A - - Google Patents

Info

Publication number
JPS57500768A
JPS57500768A JP56502116A JP50211681A JPS57500768A JP S57500768 A JPS57500768 A JP S57500768A JP 56502116 A JP56502116 A JP 56502116A JP 50211681 A JP50211681 A JP 50211681A JP S57500768 A JPS57500768 A JP S57500768A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56502116A
Other languages
Japanese (ja)
Other versions
JPH0411198B2 (cg-RX-API-DMAC10.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS57500768A publication Critical patent/JPS57500768A/ja
Publication of JPH0411198B2 publication Critical patent/JPH0411198B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP56502116A 1980-06-12 1981-06-10 Expired JPH0411198B2 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/158,685 US4393133A (en) 1980-06-12 1980-06-12 Human hepatoma derived cell line, process for preparation thereof, and uses therefor

Publications (2)

Publication Number Publication Date
JPS57500768A true JPS57500768A (cg-RX-API-DMAC10.html) 1982-05-06
JPH0411198B2 JPH0411198B2 (cg-RX-API-DMAC10.html) 1992-02-27

Family

ID=22569250

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56502116A Expired JPH0411198B2 (cg-RX-API-DMAC10.html) 1980-06-12 1981-06-10

Country Status (10)

Country Link
US (1) US4393133A (cg-RX-API-DMAC10.html)
EP (1) EP0053165B1 (cg-RX-API-DMAC10.html)
JP (1) JPH0411198B2 (cg-RX-API-DMAC10.html)
AT (1) AT391145B (cg-RX-API-DMAC10.html)
CA (1) CA1193210A (cg-RX-API-DMAC10.html)
CH (1) CH657456A5 (cg-RX-API-DMAC10.html)
DE (1) DE3152113C2 (cg-RX-API-DMAC10.html)
GB (1) GB2089370B (cg-RX-API-DMAC10.html)
IT (1) IT1171297B (cg-RX-API-DMAC10.html)
WO (1) WO1981003663A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507232A (ja) * 2013-02-01 2016-03-10 湖南省腫瘤医院Ｈｕｎａｎ Ｐｒｏｖｉｎｃｉａｌ Ｔｕｍｏｒ Ｈｏｓｐｉｔａｌ ヒト肝臓がん細胞系ｈｌｃｚ０１及びその応用

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4532204A (en) * 1982-07-19 1985-07-30 Massachusetts Institute Of Technology Mutation assays involving blood cells that metabolize toxic substances
US4808532A (en) * 1985-07-01 1989-02-28 The United States Of America As Represented By The United States Department Of Energy Continuous human cell lines and method of making same
FR2585722B1 (fr) * 1985-07-31 1987-11-20 Ire Celltarg Sa Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
US5665589A (en) * 1988-12-14 1997-09-09 The United States Of America As Represented By The Department Of Health And Human Services Human liver epithelial cell lines
US5529920A (en) * 1988-12-14 1996-06-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human liver epithelial cell line and culture media therefor
CA2081782C (en) * 1990-05-16 2004-08-24 James H. Kelly Permanent human hepatocyte cell line and its use in a liver assist device (lad)
US5704910A (en) * 1995-06-05 1998-01-06 Nephros Therapeutics, Inc. Implantable device and use therefor
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
US5869243A (en) * 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
EP2180041A3 (fr) * 2001-07-06 2010-05-26 Institut National de la Santé et de la Recherche Médicale (INSERM) Nouvelles lignees d'hepatomes humains leurs obtentions et leurs applications
CA2444292A1 (en) * 2003-10-03 2005-04-03 Inserm Bipotential liver cell lines from wild-type mammalian liver tissue
WO2005071060A2 (en) * 2004-01-08 2005-08-04 North Carolina State University Methods and devices for microencapsulation of cells
JP5623004B2 (ja) * 2004-10-25 2014-11-12 ベイラー リサーチ インスティテュートＢａｙｌｏｒ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞
JP2009525781A (ja) 2006-02-02 2009-07-16 イノベーティブ バイオ セラピーズ 細胞をベースとする体外治療装置および送達システム
US20090081296A1 (en) * 2006-02-02 2009-03-26 Humes H David Extracorporeal cell-based therapeutic device and delivery system
CA2728215A1 (en) * 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
KR101179171B1 (ko) 2008-08-14 2012-09-03 주식회사 운화 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 간질환의 예방 또는 치료용 조성물
WO2015116884A1 (en) * 2014-01-30 2015-08-06 The Cleveland Clinic Foundation In vitro assay systems and methods for identifying anti-cancer agents
WO2018187380A1 (en) * 2017-04-03 2018-10-11 Greene Nguyen Deborah Lynn Use of engineered liver tissue constructs for modeling liver disorders
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871954A (en) * 1969-08-22 1975-03-18 Nat Res Dev Cell lines and virus culture
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
FR2444713A1 (fr) * 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
US4209587A (en) * 1978-12-29 1980-06-24 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4352880A (en) * 1979-09-17 1982-10-05 Massachusetts Institute Of Technology Diffusion bioassay for the quantitative determination of mutagenicity
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
PT72015B (en) * 1979-11-13 1982-06-20 Merck & Co Inc Process for preparing "invitro" cultures of hepatitis b virus
CA1177753A (en) * 1980-03-27 1984-11-13 Paul M. Keller Method of growing hepatitis b surface antigen background of the invention
PT73614B (en) * 1980-09-11 1983-10-19 Merck & Co Inc Method for preparing mycoplasma-free hepatoma cell line
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871954A (en) * 1969-08-22 1975-03-18 Nat Res Dev Cell lines and virus culture
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016507232A (ja) * 2013-02-01 2016-03-10 湖南省腫瘤医院Ｈｕｎａｎ Ｐｒｏｖｉｎｃｉａｌ Ｔｕｍｏｒ Ｈｏｓｐｉｔａｌ ヒト肝臓がん細胞系ｈｌｃｚ０１及びその応用

Also Published As

Publication number Publication date
EP0053165A4 (en) 1983-03-04
JPH0411198B2 (cg-RX-API-DMAC10.html) 1992-02-27
IT8148663A0 (it) 1981-06-11
IT8148663A1 (it) 1982-12-11
US4393133A (en) 1983-07-12
EP0053165A1 (en) 1982-06-09
EP0053165B1 (en) 1987-05-06
AT391145B (de) 1990-08-27
CH657456A5 (de) 1986-08-29
DE3152113C2 (de) 1994-06-09
DE3152113T1 (de) 1982-08-12
ATA904881A (de) 1990-02-15
GB2089370B (en) 1984-09-05
IT1171297B (it) 1987-06-10
CA1193210A (en) 1985-09-10
WO1981003663A1 (en) 1981-12-24
GB2089370A (en) 1982-06-23

Similar Documents

Publication Publication Date Title
DE3177268D1 (cg-RX-API-DMAC10.html)
FR2473093B1 (cg-RX-API-DMAC10.html)
DE3153269A1 (cg-RX-API-DMAC10.html)
CH655428B (cg-RX-API-DMAC10.html)
FR2473923B1 (cg-RX-API-DMAC10.html)
FR2473281B1 (cg-RX-API-DMAC10.html)
DE3153460A1 (cg-RX-API-DMAC10.html)
FR2473132B1 (cg-RX-API-DMAC10.html)
DE3152263T1 (cg-RX-API-DMAC10.html)
FR2472982B1 (cg-RX-API-DMAC10.html)
FR2473847B1 (cg-RX-API-DMAC10.html)
JPS57500768A (cg-RX-API-DMAC10.html)
FR2473278B1 (cg-RX-API-DMAC10.html)
FR2473373B1 (cg-RX-API-DMAC10.html)
FR2473482B1 (cg-RX-API-DMAC10.html)
FR2473566B1 (cg-RX-API-DMAC10.html)
CH655598B (cg-RX-API-DMAC10.html)
FR2473511B1 (cg-RX-API-DMAC10.html)
DK29281A (cg-RX-API-DMAC10.html)
DE3152281T1 (cg-RX-API-DMAC10.html)
FR2473608B1 (cg-RX-API-DMAC10.html)
FR2473901B3 (cg-RX-API-DMAC10.html)
FR2473925B1 (cg-RX-API-DMAC10.html)
FR2473651B1 (cg-RX-API-DMAC10.html)
FR2473642B1 (cg-RX-API-DMAC10.html)